KLK3 and prostate cancer: However, the recent Prostate Cancer Prevention Trial reported that differences in cancer grade and stage were maintained even amongst a cohort of men who all underwent prostate biopsy [5], suggesting that detection bias due to lower PSA levels among obese individuals cannot account for all of the observed effects.